Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Solid Biosciences Inc. Director's Dealing 2020

Apr 16, 2020

33003_dirs_2020-04-16_2a489a4e-308b-4a2a-973a-26178e074a6c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2020-04-15

Reporting Person: SMITH IAN F (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-04-15 Director Stock Option (Right to Buy) $2.49 A 40000 Acquired 2030-04-15 Common Stock (40000) Direct

Footnotes

F1: This option was granted on April 15, 2020 and vests as to one-third of the total number of shares on each of the next three anniversaries of the grant date.